![November/December 2020: HIV self-testing kits in rural Lesotho proves a promising strategy to increase testing coverage in certain groups.](https://icap.columbia.edu/wp-content/uploads/header_image_IMG_2038-e1524569638715.jpg)
Journal Club
![November/December 2020: HIV self-testing kits in rural Lesotho proves a promising strategy to increase testing coverage in certain groups.](https://icap.columbia.edu/wp-content/uploads/header_image_IMG_2038-e1524569638715.jpg)
![October 2020: Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomized trial](https://icap.columbia.edu/wp-content/uploads/prep-1-1080x675.jpg)
October 2020: Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomized trial
Article and Study Summary: Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial. Published in: Lancet Glob Health. 2020;8(10):e1305-e1315....![September 2020: Community-wide HIV testing, linkage, and tracing intervention shown to move Bukoba, Tanzania, toward the 90-90-90 targets](https://icap.columbia.edu/wp-content/uploads/tz-fikia-happiness-header-1080x675.png)
September 2020: Community-wide HIV testing, linkage, and tracing intervention shown to move Bukoba, Tanzania, toward the 90-90-90 targets
Article and Study Summary: Community-wide HIV testing, linkage case management, and defaulter tracing in Bukoba, Tanzania: Pre-intervention and post-intervention, population-based survey evaluation Published in:Lancet HIV. 2020. Published online Sept 1....![August 2020: New PrEP Drug Effective for Populations At-Risk for HIV Acquisition](https://icap.columbia.edu/wp-content/uploads/prep-1080x675.jpg)
August 2020: New PrEP Drug Effective for Populations At-Risk for HIV Acquisition
Article and Study Summary: Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): Primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority...![June/July 2020: Impact of community-based multi-month dispensing of antiretroviral treatment on HIV patient retention and viral load suppression](https://icap.columbia.edu/wp-content/uploads/june-july-2020-jc-header-1080x675.jpg)